Clinical Trial Update: A Study of YKST02 in Participants With Primary IgA Nephropathy [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update for the drug YKST02 in participants with primary IgA nephropathy; the early-phase 1 study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• YKST02

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Primary IgA Nephropathy | EARLY_Phase 1 | Status: NOT_YET_RECRUITING